Trial Details
COMPLETEDBasic Information
| Clinical ID | c2519 |
|---|---|
| Identifier | NCT03359499 |
| Trial Title | Impact of Bacillus Clausii Administration on Irritable Bowel Syndrome Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome |
| Interventions | DRUG: Bacillus clausii|DRUG: Trimebutine |
Participant Information
| Sponsor | Hospital Britanico |
|---|---|
| City | Buenos Aires F.D. |
| Country/Region | Argentina |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2|PHASE3 |
Time Information
| Start Date | 2017-08-12 |
|---|---|
| Primary Completion Date | 2017-10-25 |
| Completion Date | 2017-11-23 |